CA2348102A1 - Utilisation du manganese dans le traitement des rides - Google Patents

Utilisation du manganese dans le traitement des rides Download PDF

Info

Publication number
CA2348102A1
CA2348102A1 CA002348102A CA2348102A CA2348102A1 CA 2348102 A1 CA2348102 A1 CA 2348102A1 CA 002348102 A CA002348102 A CA 002348102A CA 2348102 A CA2348102 A CA 2348102A CA 2348102 A1 CA2348102 A1 CA 2348102A1
Authority
CA
Canada
Prior art keywords
manganese
composition
salts
skin
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002348102A
Other languages
English (en)
French (fr)
Inventor
Isabelle Nonotte
Lionel Breton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of CA2348102A1 publication Critical patent/CA2348102A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002348102A 2000-05-18 2001-05-16 Utilisation du manganese dans le traitement des rides Abandoned CA2348102A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0006373 2000-05-18
FR0006373A FR2809005B1 (fr) 2000-05-18 2000-05-18 Utilisation du manganese dans le traitement des rides

Publications (1)

Publication Number Publication Date
CA2348102A1 true CA2348102A1 (fr) 2001-11-18

Family

ID=8850377

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002348102A Abandoned CA2348102A1 (fr) 2000-05-18 2001-05-16 Utilisation du manganese dans le traitement des rides

Country Status (6)

Country Link
US (2) US20020028254A1 (enExample)
EP (1) EP1155686A1 (enExample)
JP (2) JP2002003387A (enExample)
BR (1) BR0101995A (enExample)
CA (1) CA2348102A1 (enExample)
FR (1) FR2809005B1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2850573B1 (fr) * 2003-02-03 2006-07-07 Oreal Utilisation de l'acide 3-0-acetyl 11-ceto-boswellique ou d'un extrait vegetal en contenant, pour reduire les rides d'expression
FR2863164B1 (fr) * 2003-12-04 2006-02-24 Silab Sa Procede d'obtention d'un principe actif a partir de pimpinella anisum, principe actif obtenu et application cosmetique
CA2562871C (en) 2004-02-20 2014-06-10 Human Matrix Sciences, Llc Iron based compounds for elastogenesis and connective tissue treatment
FR2868309B1 (fr) * 2004-04-02 2006-05-26 Oreal Utilisation cosmetique d'au moins un inhibiteur d'hmg-coa-reductase comme agent destine a prevenir et/ou lutter contre les rides d'expression
JP2008510852A (ja) * 2004-08-17 2008-04-10 インヴィトロジェン コーポレーション 高発光性コロイド粒子の合成
JP2008536797A (ja) 2004-12-29 2008-09-11 ラボ コスプロファー アクチェンゲゼルシャフト 表情皺を緩和するのに好適な皮膚投与のための美容組成物
US7566693B2 (en) 2005-02-22 2009-07-28 Human Matrix Sciences, Llc Elastin protective polyphenolics and methods of using the same
US8114829B2 (en) 2005-02-22 2012-02-14 Human Matrix Sciences, Llc Elastin protective polyphenolics and methods of using the same
US8642578B2 (en) 2005-03-29 2014-02-04 Human Matrix Sciences, Llc Elastin protective polyphenolics and methods of using the same
ES2259928B1 (es) 2005-04-08 2007-11-01 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica que comprende peptidos derivados de encefalinas para reducir y/o eliminar arrugas faciales.
FR2893501B1 (fr) * 2005-11-21 2014-03-14 Oreal Compositions topiques pour favoriser l'homeostasie de la peau
FR2909552B1 (fr) 2006-12-12 2009-11-20 Oreal Utilisation cosmetique de l'acide anisique pour favoriser la desquamation
US8728439B2 (en) * 2008-03-31 2014-05-20 Celtrast Llc System and method for indirectly measuring calcium ion efflux
FR2932086A1 (fr) * 2008-06-06 2009-12-11 Lvmh Rech Methode de soin cosmetique anti-age par stimulation de l'expression de la survivine
WO2010093635A2 (en) 2009-02-10 2010-08-19 Celtrast Llc Systems and methods for measuring and modeling in vivo manganese ion transport in a subject
FR2953716B1 (fr) 2009-12-16 2015-03-27 Oreal Kit de formulation d'un produit cosmetique
US20110305735A1 (en) 2010-06-09 2011-12-15 Lipotec, S.A. Skin antiaging treatment
CN106456469A (zh) * 2014-04-28 2017-02-22 堺化学工业株式会社 化妆料
FR3061002B1 (fr) 2016-12-23 2019-05-24 L'oreal Composition comprenant de l’acide hydroxyethylpiperazine ethane sulfonique et au moins un alkylpolyglucoside

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2612775B1 (fr) * 1987-03-25 1991-10-11 Thorel Jean Compositions pour la prevention et le traitement de la degenerescence cutanee
EP0424033A3 (en) * 1989-10-19 1991-07-31 Pola Chemical Industries Inc External skin preparation
FR2675997B1 (fr) * 1991-05-03 1993-12-24 Oreal Composition topique anti radicaux libres a base de superoxyde-dismutase et d'un derive phosphonique.
US5496827A (en) * 1994-07-15 1996-03-05 Patrick; Jay Compositions for the transdermal delivery of nutrients
EP0799018A4 (en) * 1994-12-21 2000-03-29 Cosmederm Technologies FORMULATIONS AND METHODS FOR REDUCING SKIN IRRITATION
FR2740335B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, de lithium, d'etain, de zinc, de manganese ou d'yttrium comme antagoniste de substance p
GB2307175A (en) * 1995-11-14 1997-05-21 Steifel Lab Inc Topical composition comprising a transition metal and bicarbonate ions, particularly for the promotion of pigmentation
JP3608059B2 (ja) * 1995-12-05 2005-01-05 株式会社アドバンス 化粧料
US5925348A (en) * 1996-02-23 1999-07-20 Medical Doctor's Research Institute, Inc. Methods utilizing compositions containing sacred lotus (methyltransferase) to treat aging skin
FR2746641B1 (fr) * 1996-03-27 1998-06-05 Oreal Utilisation d'un extrait d'au moins une iridacee dans le traitement des rides
US6471972B1 (en) * 1996-11-07 2002-10-29 Lvmh Recherche Cosmetic treatment method for fighting against skin ageing effects
FR2779059B1 (fr) * 1998-05-29 2004-09-10 Guerlain Procede de traitement cosmetique pour lutter contre les effets du vieillissement cutane; nouvelles compositions cosmetiques pour sa mise en oeuvre
US5804594A (en) * 1997-01-22 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for improving wrinkles and other skin conditions
US6149924A (en) * 1998-07-20 2000-11-21 Biomed Research & Technologies, Inc. Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin
FR2791260B1 (fr) * 1999-03-26 2003-06-06 Dior Christian Parfums Compositions cosmetiques ou dermatologiques contenant au moins une substance destinee a augmenter la fonctionnalite et/ou l'expression des recepteurs membranaires cd44 des cellules de la peau

Also Published As

Publication number Publication date
JP2002003387A (ja) 2002-01-09
US20040096520A1 (en) 2004-05-20
BR0101995A (pt) 2002-03-19
US20020028254A1 (en) 2002-03-07
FR2809005B1 (fr) 2002-12-27
FR2809005A1 (fr) 2001-11-23
EP1155686A1 (fr) 2001-11-21
JP2007277274A (ja) 2007-10-25

Similar Documents

Publication Publication Date Title
CA2308873C (fr) Utilisation d'au moins un inhibiteur d'au moins un canal calcique dans le traitement des rides
CA2201163C (fr) Utilisation d'un extrait d'au moins une iridacee dans le traitement des rides
CA2159555C (fr) Utilisation d'une substance agoniste d'un recepteur associe a un canal chlore dans le traitement des rides
CA2185036C (fr) Utilisation d'un extrait d'une bacterie filamenteuse non photosynthetique et composition le contenant
CA2348102A1 (fr) Utilisation du manganese dans le traitement des rides
EP0709084B1 (fr) Utilisation d'une huile riche en acide pétrosélinique comme agent hydratant
CA2319842A1 (fr) Utilisation de l'alverine pour diminuer les rides
FR2751537A1 (fr) Utilisation du miel comme agent keratolytique, notamment pour ameliorer l'eclat du teint de la peau et traiter les rides
FR2799369A1 (fr) Association d'escine et de sulfate de dextran et son utilisation
CA3164351A1 (fr) Procede d'obtention d'un extrait aqueux de lavande, compositions comprenant un tel extrait et leurs utilisations cosmetiques
WO2001082940A1 (fr) Extrait de vegetal de l'espece olea europaea comme inhibiteur de no-synthase et utilisations
EP0993826A1 (fr) Utilisation d' un extrait de sanguisorba officinalis pour favoriser la pigmentation de la peau et/ou des cheveux
CA2322149A1 (fr) Utilisation d'un compose inhibant l'activite d'un canal sodium ou d'un canal calcium dans une composition a usage topique
FR2738485A1 (fr) Utilisation d'au moins un extrait d'au moins une bacterie filamenteuse non photosynthetique en tant qu'antagoniste de substance p
EP1155685B1 (fr) Composition comprenant du manganèse
FR3133312A1 (fr) Utilisation cosmétique ou dermatologique de Sphingomonas glacialis et/ou d’une composition la comprenant
FR3139466A1 (fr) Utilisation d’un extrait de poivrier de Sichuan pour un traitement cutané et une composition adaptée à cette utilisation.
FR3123807A1 (fr) Serum cosmetique activateur et utilisation dans un procede de soin cosmetique
WO2024134082A1 (fr) Nouvelles utilisations d'un extrait de phaeodactylum tricornutum
FR2738486A1 (fr) Utilisation d'au moins un extrait d'au moins une iridacee dans une composition cosmetique ou pharmaceutique
FR2818131A1 (fr) Composition cosmetique comprenant de l'heparanase
FR2828098A1 (fr) Utilisation d'un substitut biotechnologique de miel comme agent anti-inflammatoire
FR2968988A1 (fr) Huile essentielle de fabiana imbricata a titre d'agent apaisant.

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead